EXHIBIT 10.4


                                    AGREEMENT


This Agreement, made effective November 25, 1996, by and between Adam Kristcher
("Kristcher") and Biomune Systems, Inc., a Nevada Corporation ("Biomune");

NOW THEREFORE, the parties agree as follows:

1.   Engagement, Duties and Acceptance

     1.1  Engagement by Biomune. Biomune hereby agrees to retain Kristcher for
          the following purposes:

          (a)  Provide introductions to potential business partners;

          (b)  Provide introductions and information to and about potential
               business partners.

     1.2  Acceptance of Engagement by Kristcher. Kristcher hereby accepts such
          engagement and shall render management services as described above.

2.   Term of Agreement. The term of Kristcher's engagement under this Agreement
     (the "Term") shall commence on November 1, 1996 (the "Commencement Date")
     and shall continue through and expire on the 30th day of March, 1997,
     unless sooner terminated by either Biomune or Kristcher upon thirty (30)
     days written notice. This Agreement may continue in effect beyond the Term
     if mutually agreed in writing by both Biomune and Kristcher.

3.   Compensation. As compensation for services to be rendered pursuant to this
     Agreement, Biomune shall pay Kristcher 30,000 shares of Biomune common
     stock that will be registered pursuant to an S-8 registration statement.

4.   Confidential Information. During the Term of this Agreement and for a
     period of five (5) years after the termination of this Agreement, Kristcher
     shall keep secret and retain in strictist confidence and shall not use, for
     the benefit of itself or others, all confidential matters of the Biomune
     including, without limitation, "know-how", trade secrets, customer lists,
     details of client or consultant contracts, pricing policies, operational
     methods, marketing plans or strategies, product development techniques or
     plans, methods of production and distribution, technical processes, designs
     and design projects, inventions and research projects of Biomune learned by
     Kristcher heretofore or during the Term hereof.




5.   Other Provisions.

     5.1  Any notice or other communication required or permitted hereunder
          shall be in writing and shall be delivered personally, telegraphed,
          telexed, sent by facsimile transmission or sent by certified,
          registered or express mail, postage prepaid. Any such notice shall be
          deemed given when so delivered personally, telegraphed, telexed or
          sent by facsimile transmission or, if maile, five days after the date
          of deposit in the United States mail, as follows:

          (i)  if to Biomune, to:

               Biomune Systems, Inc.
               2401 South Foothill
               Drive Salt Lake City, Utah 84109

               with a copy to:

               Nolan Taylor, Esquire
               LeBoeuf, Lamb, Greene & MacRae
               1000 Kearns Building
               136 South Main Street
               Salt Lake City, Utah 84101

          (ii) if to Kristcher, to:

               100 Daly Blvd.
               Unit 2807
               Oceanside, New York 11572


     5.2  Entire Agreement. This Agreement contains the entire agreement between
          the parties with respect to the subject matter hereof and supersedes
          all prior agreement, written or oral, with respect thereto.

     5.3  Governing Law; Venue. This Agreement shall be governed and construed
          in accordance with the laws of the State of Utah applicable to
          agreements made and to be performed entirely within such state. The
          parties submit themselves to the jurisdiction of the federal and state
          courts located in Utah and agree to commence any lawsuit arising under
          or relating to this Agreement in such courts.





     5.4  Assignment. This Agreement, and any rights and obligations hereunder,
          may not be assigned by any party hereto without the prior written
          consent of the other party.

     5.5  Headings. The headings in this Agreement are for reference purposes
          only and shall not in any way affect the meaning or interpretation of
          this Agreement.

IN WITNESS WHEREOF, the parties have executed this Agreement effective as of the
date first above-written.


               BIOMUNE SYSTEMS, INC.


         By:   /s/  Michael G. Acton

         Its:  Chief Financial Officer


               KRISTCHER


               /s/  Adam Kristcher
               Adam Kristcher